265 related articles for article (PubMed ID: 32902014)
1. Distinct microglial and macrophage distribution patterns in the concentric and lamellar lesions in Baló's disease and neuromyelitis optica spectrum disorders.
Hayashida S; Masaki K; Suzuki SO; Yamasaki R; Watanabe M; Koyama S; Isobe N; Matsushita T; Takahashi K; Tabira T; Iwaki T; Kira JI
Brain Pathol; 2020 Nov; 30(6):1144-1157. PubMed ID: 32902014
[TBL] [Abstract][Full Text] [Related]
2. [Recent progress in multiple sclerosis research: astrocytopathy in demyelinating diseases].
Kira J
Rinsho Shinkeigaku; 2010 Nov; 50(11):788-93. PubMed ID: 21921443
[TBL] [Abstract][Full Text] [Related]
3. Astrocytopathy in Balo's disease.
Kira J
Mult Scler; 2011 Jul; 17(7):771-9. PubMed ID: 21459811
[TBL] [Abstract][Full Text] [Related]
4. Early disruption of glial communication via connexin gap junction in multiple sclerosis, Baló's disease and neuromyelitis optica.
Masaki K
Neuropathology; 2015 Oct; 35(5):469-80. PubMed ID: 26016402
[TBL] [Abstract][Full Text] [Related]
5. Regulation of microglial TMEM119 and P2RY12 immunoreactivity in multiple sclerosis white and grey matter lesions is dependent on their inflammatory environment.
van Wageningen TA; Vlaar E; Kooij G; Jongenelen CAM; Geurts JJG; van Dam AM
Acta Neuropathol Commun; 2019 Dec; 7(1):206. PubMed ID: 31829283
[TBL] [Abstract][Full Text] [Related]
6. Reappraisal of aquaporin-4 astrocytopathy in Asian neuromyelitis optica and multiple sclerosis patients.
Matsuoka T; Suzuki SO; Suenaga T; Iwaki T; Kira J
Brain Pathol; 2011 Sep; 21(5):516-32. PubMed ID: 21241398
[TBL] [Abstract][Full Text] [Related]
7. Tissue preconditioning may explain concentric lesions in Baló's type of multiple sclerosis.
Stadelmann C; Ludwin S; Tabira T; Guseo A; Lucchinetti CF; Leel-Ossy L; Ordinario AT; Brück W; Lassmann H
Brain; 2005 May; 128(Pt 5):979-87. PubMed ID: 15774507
[TBL] [Abstract][Full Text] [Related]
8. Aquaporin-4 astrocytopathy in Baló's disease.
Matsuoka T; Suzuki SO; Iwaki T; Tabira T; Ordinario AT; Kira J
Acta Neuropathol; 2010 Nov; 120(5):651-60. PubMed ID: 20680636
[TBL] [Abstract][Full Text] [Related]
9. Extensive loss of connexins in Baló's disease: evidence for an auto-antibody-independent astrocytopathy via impaired astrocyte-oligodendrocyte/myelin interaction.
Masaki K; Suzuki SO; Matsushita T; Yonekawa T; Matsuoka T; Isobe N; Motomura K; Wu XM; Tabira T; Iwaki T; Kira J
Acta Neuropathol; 2012 Jun; 123(6):887-900. PubMed ID: 22438105
[TBL] [Abstract][Full Text] [Related]
10. Antibody signatures in patients with histopathologically defined multiple sclerosis patterns.
Stork L; Ellenberger D; Ruprecht K; Reindl M; Beißbarth T; Friede T; Kümpfel T; Gerdes LA; Gloth M; Liman T; Paul F; Brück W; Metz I
Acta Neuropathol; 2020 Mar; 139(3):547-564. PubMed ID: 31950335
[TBL] [Abstract][Full Text] [Related]
11. [Astrocytopathy in neuromyelitis optica, multiple sclerosis and Baló's disease].
Matsushita T; Masaki K; Suzuki S; Matsuoka T; Yonekawa T; Wu XM; Tabira T; Iwaki T; Kira J
Rinsho Shinkeigaku; 2011 Nov; 51(11):898-900. PubMed ID: 22277409
[TBL] [Abstract][Full Text] [Related]
12. Baló's concentric sclerosis: imaging findings and pathological correlation.
Darke M; Bahador FM; Miller DC; Litofsky NS; Ahsan H
J Radiol Case Rep; 2013 Jun; 7(6):1-8. PubMed ID: 24421937
[TBL] [Abstract][Full Text] [Related]
13. Baló's concentric sclerosis: surviving normal myelin in a patient with a relapsing-remitting dinical course.
Moore GR; Berry K; Oger JJ; Prout AJ; Graeb DA; Nugent RA
Mult Scler; 2001 Dec; 7(6):375-82. PubMed ID: 11795459
[TBL] [Abstract][Full Text] [Related]
14. Anti-aquaporin-4 antibody-seronegative NMO spectrum disorder with Baló's concentric lesions.
Masuda H; Mori M; Katayama K; Kikkawa Y; Kuwabara S
Intern Med; 2013; 52(13):1517-21. PubMed ID: 23812202
[TBL] [Abstract][Full Text] [Related]
15. Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders.
Kira J
J Neurol Sci; 2011 Dec; 311(1-2):69-77. PubMed ID: 21962794
[TBL] [Abstract][Full Text] [Related]
16. MRI signs of CNS demyelinating diseases.
Etemadifar M; Ashourizadeh H; Nouri H; Kargaran PK; Salari M; Rayani M; Aghababaee A; Abhari AP
Mult Scler Relat Disord; 2021 Jan; 47():102665. PubMed ID: 33310421
[TBL] [Abstract][Full Text] [Related]
17. TMEM119 marks a subset of microglia in the human brain.
Satoh J; Kino Y; Asahina N; Takitani M; Miyoshi J; Ishida T; Saito Y
Neuropathology; 2016 Feb; 36(1):39-49. PubMed ID: 26250788
[TBL] [Abstract][Full Text] [Related]
18. Baló's concentric sclerosis is immunologically distinct from multiple sclerosis: results from retrospective analysis of almost 150 lumbar punctures.
Jarius S; Würthwein C; Behrens JR; Wanner J; Haas J; Paul F; Wildemann B
J Neuroinflammation; 2018 Jan; 15(1):22. PubMed ID: 29347989
[TBL] [Abstract][Full Text] [Related]
19. [Connexin astrocytopathy and novel therapeutic strategy targeting connexin hemichannels in demyelinating disease].
Masaki K
Rinsho Shinkeigaku; 2012; 52(11):1354-6. PubMed ID: 23196616
[TBL] [Abstract][Full Text] [Related]
20. [Balò's concentric sclerosis in a North-African patient].
Nagi S; Megdiche H; Mrabet H; Sebaï R; Chaâbane S; Belghith L; Touibi S
Rev Neurol (Paris); 2005 Jan; 161(1):78-80. PubMed ID: 15678005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
